2023.12.29
Academic Conferences at Home and Abroad ···
❖ TaurusOne® Transcatheter Aortic Valve Replacement (TAVR) System■ Four-Year Clinical Follow-up Resu···
2023.12.22
Shanghai Renji Hospital Completed the Fi···
Achieva Medical initiated a prospective, multi-center, randomized-controlled clinical trial to evalu···
2023.11.01
Prof. Yu Bo's Team at the Second Affilia···
On October 31, 2023, the team led by Prof. Yu Bo at the Second Affiliated Hospital of Harbin Medical···
2023.07.31
Professor Song Guangyuan and His Team at···
On July 26, 2023, Professor Song Guangyuan, the Director of the Heart Valve Intervention Center at B···
2023.07.07
NMPA APPROVAL FOR REGISTRATION APPLICATI···
This announcement is made by Peijia Medical Limited (the “Company”, together with its
subsidiaries,···
2023.05.18
First Asian Commercial Implants with the···
On May 12th, 2023, Dr. Michael Lee and his team from the Cardiology Department of Queen Elizabeth Ho···
2022.12.04
FIRST PATIENT ENROLLMENT IN THE MULTI-CE···
FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER
REGISTRATION CLINICAL TRIAL OF GeminiOne®
TRANSCATHET···
2022.11.25
FIRST PATIENT IMPLANT IN THE FIRST-IN-MA···
FIRST PATIENT IMPLANT IN THE FIRST-IN-MAN CLINICAL
TRIAL OF THE MonarQ TRANSCATHETER TRICUSPID VALV···
2022.11.14
FIRST PATIENT IMPLANT IN MULTI-CENTER RE···
FIRST PATIENT IMPLANT IN MULTI-CENTER REGISTRATION
CLINICAL TRIAL OF PEIJIA HighLife® TRANSCATHETER···
2024.10.18
ONE-YEAR CLINICAL FOLLOW-UP RESULTS OF T···
From October 9-16, 2024, China Structural Week
2024 was grandly held. TaurusNXT® ❖ New Third-G···
2022.06.09
Peijia Medical Fluxcap® Balloon Guide Ca···
On June 8, 2022, Peijia Medical received the approval from the National Medical Products Administrat···
2022.05.24
Peijia Medical Tethys AS® Aspiration Cat···
Peijia Medical Tethys AS® Aspiration Catheter and Fastunnel® Delivery Balloon Dilation Catheter Obta···
